Literature DB >> 15326118

Ocular dominance column width and contrast sensitivity in monkeys reared with strabismus or anisometropia.

Morris L J Crawford1, Ronald S Harwerth.   

Abstract

PURPOSE: To study the relationship between the width of ocular dominance columns in primary visual cortex and spatial contrast sensitivity functions in monkeys with strabismus or anisometropia during infancy.
METHODS: Adult monkeys having had monocular visual abnormalities induced in infancy were tested behaviorally for spatial contrast sensitivity and then subjected to functional enucleation of one eye to reveal the ocular dominance columns (ODCs) of the primary visual cortex by cytochrome oxidase (CO) staining. The relative widths of the left and right eyes' ODCs were measured and related to the contrast sensitivity functions.
RESULTS: The relative widths of the ODCs having input from eyes with strabismic or anisometropic amblyopia were reduced in proportion to the age of onset and the duration of the early visual abnormality. The relative losses in contrast sensitivity were in ordinal agreement with the losses in relative width of the ODCs.
CONCLUSIONS: Amblyopia induced by the early monocular abnormalities of strabismus or anisometropia is proportional to the loss in cortical afference as reflected in the reduction in width of the respective ODCs in the primary visual cortex. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326118     DOI: 10.1167/iovs.04-0029

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Monocular activation of V1 and V2 in amblyopic adults measured with functional magnetic resonance imaging.

Authors:  Ian P Conner; J Vernon Odom; Terry L Schwartz; Janine D Mendola
Journal:  J AAPOS       Date:  2007-04-16       Impact factor: 1.220

2.  Retinotopic maps and foveal suppression in the visual cortex of amblyopic adults.

Authors:  Ian P Conner; J Vernon Odom; Terry L Schwartz; Janine D Mendola
Journal:  J Physiol       Date:  2007-07-12       Impact factor: 5.182

3.  Altered functional interactions between neurons in primary visual cortex of macaque monkeys with experimental amblyopia.

Authors:  Katerina Acar; Lynne Kiorpes; J Anthony Movshon; Matthew A Smith
Journal:  J Neurophysiol       Date:  2019-09-25       Impact factor: 2.714

4.  Acuity-independent effects of visual deprivation on human visual cortex.

Authors:  Chuan Hou; Mark W Pettet; Anthony M Norcia
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  Beyond Rehabilitation of Acuity, Ocular Alignment, and Binocularity in Infantile Strabismus.

Authors:  Chantal Milleret; Emmanuel Bui Quoc
Journal:  Front Syst Neurosci       Date:  2018-07-18

6.  Neuronal responses in visual area V2 (V2) of macaque monkeys with strabismic amblyopia.

Authors:  H Bi; B Zhang; X Tao; R S Harwerth; E L Smith; Y M Chino
Journal:  Cereb Cortex       Date:  2011-01-24       Impact factor: 5.357

7.  Which hyperopic patients are destined for trouble?

Authors:  T Rowan Candy
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

8.  Functional neuroimaging to characterize visual system development in children with retinoblastoma.

Authors:  Scott M Barb; Carlos Rodriguez-Galindo; Matthew W Wilson; Nicholas S Phillips; Ping Zou; Matthew A Scoggins; Yimei Li; Ibrahim Qaddoumi; Kathleen J Helton; George Bikhazi; Barrett G Haik; Robert J Ogg
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

9.  Spatial summation across the visual field in strabismic and anisometropic amblyopia.

Authors:  Shindy Je; Fergal A Ennis; J Margaret Woodhouse; Frank Sengpiel; Tony Redmond
Journal:  Sci Rep       Date:  2018-03-01       Impact factor: 4.379

10.  Human infants can generate vergence responses to retinal disparity by 5 to 10 weeks of age.

Authors:  Eric S Seemiller; Bruce G Cumming; T Rowan Candy
Journal:  J Vis       Date:  2018-06-01       Impact factor: 2.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.